Wellington Management Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Buy
493,083
+5,841
+1% +$12.1K ﹤0.01% 1709
2025
Q1
$1.07M Sell
487,242
-880
-0.2% -$1.94K ﹤0.01% 1688
2024
Q4
$747K Sell
488,122
-8,105
-2% -$12.4K ﹤0.01% 1758
2024
Q3
$987K Sell
496,227
-24,967
-5% -$49.7K ﹤0.01% 1698
2024
Q2
$1.82M Buy
521,194
+103,209
+25% +$361K ﹤0.01% 1537
2024
Q1
$1.16M Buy
+417,985
New +$1.16M ﹤0.01% 1650
2023
Q2
Sell
-312,286
Closed -$472K 1891
2023
Q1
$472K Sell
312,286
-14,368
-4% -$21.7K ﹤0.01% 1847
2022
Q4
$817K Sell
326,654
-6,257
-2% -$15.6K ﹤0.01% 1685
2022
Q3
$1.41M Sell
332,911
-90,682
-21% -$383K ﹤0.01% 1592
2022
Q2
$1.18M Sell
423,593
-1,306,179
-76% -$3.64M ﹤0.01% 1648
2022
Q1
$9.89M Buy
1,729,772
+91,499
+6% +$523K ﹤0.01% 1200
2021
Q4
$15M Sell
1,638,273
-784,149
-32% -$7.16M ﹤0.01% 1146
2021
Q3
$25.9M Sell
2,422,422
-1,799,267
-43% -$19.2M ﹤0.01% 1014
2021
Q2
$65.5M Sell
4,221,689
-1,625,659
-28% -$25.2M 0.01% 744
2021
Q1
$94.8M Sell
5,847,348
-1,088,566
-16% -$17.6M 0.02% 623
2020
Q4
$147M Buy
6,935,914
+3,322,618
+92% +$70.3M 0.03% 486
2020
Q3
$53.6M Buy
3,613,296
+488,201
+16% +$7.24M 0.01% 678
2020
Q2
$46M Buy
3,125,095
+685,099
+28% +$10.1M 0.01% 720
2020
Q1
$28.6M Sell
2,439,996
-2,057,833
-46% -$24.2M 0.01% 783
2019
Q4
$106M Buy
4,497,829
+108,312
+2% +$2.55M 0.02% 551
2019
Q3
$81.2M Sell
4,389,517
-408,221
-9% -$7.55M 0.02% 597
2019
Q2
$89.2M Sell
4,797,738
-347,250
-7% -$6.46M 0.02% 595
2019
Q1
$126M Buy
5,144,988
+567,117
+12% +$13.9M 0.03% 496
2018
Q4
$119M Sell
4,577,871
-35,446
-0.8% -$919K 0.03% 454
2018
Q3
$146M Sell
4,613,317
-156,858
-3% -$4.96M 0.03% 465
2018
Q2
$185M Buy
4,770,175
+2,597,229
+120% +$101M 0.04% 397
2018
Q1
$60M Buy
+2,172,946
New +$60M 0.01% 724